Ultimately, the incorporation of automated quantitative measures of breast density will lead to more effective clinical care and more robust outcomes research than the current, subjective assignment of Breast Imaging and Reporting Data System density categories, by providing reproducible estimates of both the risk of masking a cancer as well as the risk of developing breast cancer—two important factors in determining personalized breast cancer screening algorithms.